Gapping down
In reaction to earnings/guidance:
- CGNT -28.8%, LNN -0.6%
Other news:
- XPOF -6.9% (announced secondary offering of common stock by selling stockholders) TRIN -4.2% (announced public offering of common stock)
- FLDM -1.3% (completes $250 mln strategic capital infusion; changes name to "Standard BioTools")
- BIIB -1.2% (presented new data from multiple sclerosis portfolio at AAN 2022)
Analyst comments:
- BRCC -15.1% (downgraded to Mkt Perform from Outperform at Raymond James)
- CVNA -3.7% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)
- CFG -0.8% (downgraded to Mkt Perform from Outperform at Keefe Bruyette)
